Molina Healthcare, Inc. (MOH) Q4 2022 Earnings Call Transcript
Molina Healthcare, Inc. (NYSE:MOH) Q4 2022 Earnings Conference Call February 9, 2023 8:00 AM ET
Company Participants
Joe Krocheski - SVP, IR
Joe Zubretsky - President & CEO
Mark Keim - CFO
Conference Call Participants
Josh Raskin - Nephron Research
A.J. Rice - Credit Suisse
Justin Lake - Wolfe Research
Calvin Sternick - JPMorgan
Scott Fidel - Stephens
Michael Hall - Morgan Stanley
Stephen Baxter - Wells Fargo
Nathan Rich - Goldman Sachs
Gary Taylor - Cowen
Steven Valiquette - Barclays
Kevin Fischbeck - Bank of America
David Windley - Jefferies
Operator
Good morning, and welcome to Molina Healthcare’s Fourth Quarter 2022 Earnings Call. All participants will be in listen-only mode. [Operator Instructions] After today’s presentation, there will be an opportunity to ask questions. [Operator Instructions] Please note this event is being recorded.
I would now like to turn the conference over to Joe Krocheski, Senior Vice President, Molina Healthcare. Please go ahead.
Joe Krocheski
Good morning, and welcome to Molina Healthcare's fourth quarter 2022 earnings call. Joining me today are Molina's President and CEO, Joe Zubretsky; and our CFO, Mark Keim. A press release announcing our fourth quarter earnings was distributed after the market closed yesterday and is available on our Investor Relations website.
Shortly after the conclusion of this call, a replay will be available for 30 days. The numbers to access the replay are in the earnings release. For those of you who listen to the rebroadcast of this presentation, we remind you that the remarks made are as of today, Thursday, February 9, 2023. It has not been updated subsequent to the initial earnings call.
On this call, we will refer to certain non-GAAP measures. A reconciliation of these measures with the most directly comparable GAAP measures for 2022 and 2023 can be found in our fourth quarter 2022 press release.
During our call, we will be making certain forward-looking statements, including, but not limited to, statements regarding our 2023 guidance, our projected 2024 outlook and revenue, our recent RFP awards, recent and future RFP submissions, including those in Indiana, New Mexico and Florida, our acquisitions and M&A activity, Medicaid lease terminations, our long term growth strategy and our embedded earnings power and margins.
Listeners are cautioned that all of our forward-looking statements are subject to certain risks and uncertainties that could cause our actual results to differ materially from our current expectations. We advise listeners to review the risk factors discussed in our Form 10-K annual report filed with the SEC, as well as the risk factors listed in our Form 10-Q and Form 8-K filings with the SEC. After the completion of our prepared remarks, we will open the call to take your questions.